Theratechnologies to Present at the H.C. Wainwright 5th Annual Nash Investor Conference
Theratechnologies (NASDAQ: THTX) announced that Dr. Christian Marsolais, Senior Vice President and Chief Medical Officer, will speak at the H.C. Wainwright 5th Annual NASH Investor Conference on October 12, 2021, at 4:30 p.m. ET. A live webcast of his presentation will be accessible on the company’s investor relations website and archived for 90 days. Theratechnologies focuses on developing innovative therapies to meet unmet medical needs. For more information, visit theratech.com.
- None.
- None.
MONTREAL, Oct. 06, 2021 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and commercialization of innovative therapies, today announced that Christian Marsolais, Ph.D., Senior Vice President and Chief Medical Officer, will participate at the H.C. Wainwright 5th Annual NASH Investor Conference on Tuesday, October 12, 2021 at 4:30 p.m. ET.
A live webcast of Dr. Marsolais’ presentation will be available through the ‘Events’ section of the Company’s investor relations website and will be archived for 90 days.
About Theratechnologies
Theratechnologies (TSX: TH) (NASDAQ: THTX) is a biopharmaceutical company focused on the development and commercialization of innovative therapies addressing unmet medical needs. Further information about Theratechnologies is available on the Company's website at www.theratech.com, on SEDAR at www.sedar.com and on EDGAR at www.sec.gov.
For investor and media inquiries:
Leah Gibson
Senior Director, Investor Relations
communications@theratech.com
617-356-1009
FAQ
When will Dr. Christian Marsolais present at the H.C. Wainwright NASH Investor Conference for THTX?
How can I access the webcast of Dr. Marsolais’ presentation for THTX?
What is the focus of Theratechnologies, the company represented by THTX?
Where can I find more information about Theratechnologies and THTX?
